2026 ETA guideline on interference in immunoassay measurements used in assessment of thyroid function
European Thyroid Journal · 01.08.2026 · 15 (4)
DOI: 10.1530/etj-26-0011 ↗Kurz gefasst
Leitlinie in der Zeitschrift European Thyroid Journal, online erschienen am 17.07.2026. Verfasst von Irene Campi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano , Milan, Italy. Hauptthemen laut MEDLINE: Thyroid Function Tests, Thyroid Gland. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Although measurement of thyroid hormones (THs), TSH and thyroid autoantibodies, is usually straightforward, erroneous results are occasionally generated, raising the possibility of incorrect or delayed diagnoses, unwarranted investigations, and provision of inappropriate treatments. Assay interference can be acquired (e.g. antibodies), genetic (e.g. variant TH-binding proteins), or pharmaceutical (e.g. displacing agents and biotin) in nature. In those with discordant thyroid function, assay interference must be excluded prior to the diagnosis of rare inherited (resistance to thyroid hormone) or tumoural conditions (TSHoma). Liaison between the clinician and clinical biochemistry teams is essential when assay interference is being investigated; appropriate further biochemical testing depends on the clinical picture, initial biochemistry, and local biochemical expertise. In a subset of cases, access to a regional centre where patients can be clinically assessed, in conjunction with performance of specialised clinical laboratory testing (biochemical, +/− genetic), may be required. When assay interference is identified, clear communication with the patient (ideally aided by reliable, accessible patient literature) and documentation to their physician are necessary. Professionals must stay updated on advances in testing and be alert for evolving assay interferences. An accompanying plain language summary is intended to provide an accessible overview of the key messages and recommendations contained in this guideline for non-specialist readers, including patients, carers, healthcare professionals outside the speciality, and the wider public.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrine and Metabolic Diseases, IRCCS Istituto Auxologico Italiano , Milan, Italy.
- Department of Nephrology and Endocrinology, Copenhagen University Hospital, Rigshospitalet , Copenhagen, Denmark.
- Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen , Copenhagen, Denmark.
- Department of Clinical Biochemistry, Cliniques Universitaires St-Luc, UC Louvain , Brussels, Belgium.
- Department of Clinical Biochemistry, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust , Cambridge, UK.
- Service de Biochimie et Biologie Moléculaire, Laboratoire de Biologie Médicale Multi-Sites (LBMMS), Hospices Civils de Lyon , Lyon, France.
ORCID-Profile: Veronique Raverot, Carla Moran
Zitieren
APA
Campi, I., Feldt-Rasmussen, U., Gruson, D., Halsall, D., Raverot, V., van den Berg, S., & Moran, C. (2026). 2026 ETA guideline on interference in immunoassay measurements used in assessment of thyroid function. European Thyroid Journal, 15(4). https://doi.org/10.1530/etj-26-0011
Vancouver
Campi I, Feldt-Rasmussen U, Gruson D, Halsall D, Raverot V, van den Berg S, et al. 2026 ETA guideline on interference in immunoassay measurements used in assessment of thyroid function. European Thyroid Journal. 2026;15(4). doi:10.1530/etj-26-0011
BibTeX
@article{Campi2026,
author = {Campi, Irene and Feldt-Rasmussen, Ulla and Gruson, Damien and Halsall, David and Raverot, Veronique and van den Berg, Sjoerd and Moran, Carla},
title = {2026 ETA guideline on interference in immunoassay measurements used in assessment of thyroid function},
journal = {European Thyroid Journal},
year = {2026},
volume = {15},
number = {4},
doi = {10.1530/etj-26-0011}
}
EUVIMED